SLOUGH, England and
RICHMOND, Va., Jan. 4, 2018 /PRNewswire/ -- Indivior PLC
(LON: INDV) today announced that Shaun
Thaxter, CEO, will present at the 36th Annual
J.P. Morgan Healthcare Conference on January
11th, 2018, at 8:30 a.m. local
Pacific time (11:30 a.m. Eastern /
4:30 p.m. GMT) from the Westin St.
Francis Hotel in San Francisco.
Mark Crossley, CFO, and Jason Thompson, VP of Investor Relations, will
also be in attendance. Thaxter will review Indivior's business and
outlook. The presentation will be webcast live and, along with the
presentation materials, will be available to the public on the
"Investors" section of Indivior's website (www.indivior.com).
About Indivior
Indivior is a global specialty pharmaceutical company with a
20-year legacy of leadership in patient advocacy and health policy
while providing education on evidence-based treatment models that
have revolutionized modern addiction treatment. The name is the
fusion of the words individual and endeavour, and the tagline
"Focus on you" makes the Company's commitment clear. Indivior is
dedicated to transforming addiction from a global human crisis to a
recognized and treated chronic disease. Building on its global
portfolio of opioid dependence treatments, Indivior has a strong
pipeline of product candidates designed to both expand on its
heritage in this category and address other chronic conditions and
co-occurring disorders of addiction, including alcohol use disorder
and schizophrenia. Headquartered in the
United States in Richmond,
VA, Indivior employs more than 900 individuals globally and
its portfolio of products is available in over 40 countries
worldwide. Visit www.indivior.com to learn more.
View original
content:http://www.prnewswire.com/news-releases/indiviors-shaun-thaxter-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-on-january-11th-300577220.html
SOURCE Indivior PLC